Increased Incidence of Breast Cancer in Postmenopausal Women with High Body Mass Index at the Modena Screening Program
- PMID: 27721878
- PMCID: PMC5053313
- DOI: 10.4048/jbc.2016.19.3.283
Increased Incidence of Breast Cancer in Postmenopausal Women with High Body Mass Index at the Modena Screening Program
Abstract
Purpose: We conducted a study to evaluate the relationship between body mass index (BMI) and the risk of breast cancer (BC) and outcome in a population of 14,684 women aged 55 to 69 years eligible to participate in the Mammography Screening Program (MSP) in the Province of Modena, Italy.
Methods: The study population was drawn from women who underwent mammography screening between 2004 and 2006 in the Province of Modena. Women were subdivided into obese, overweight, and normal-weight categories according to BMI and followed until July 31, 2010, to evaluate the BC incidence. The clinicopathological characteristics of BC were also evaluated in different groups of patients classified according to BMI. After BC diagnosis, patients were followed for a median period of 65 (range, 2-104) months. Second events (recurrences and second tumors) were recorded, and the 5-year event-free survival (EFS) was calculated.
Results: After a period of 73 months, 366 cases of BC were diagnosed. Compared with normal-weight women, obese women had a significantly higher incidence of BC (relative risk [RR], 1.32; p=0.040) (RR=1), larger tumors (27% of tumors were larger than T2 size), and more nodal involvement (38.5% of tumors were node-positive). Furthermore, a significantly higher rate of total events was seen in obese women compared with overweight and normal-weight patients, respectively (17.9% vs. 11.4% vs. 10.8%, p=0.032). The 5-year EFS was 89.0%, 89.0%, and 80.0% for normal-weight, overweight, and obese patients, respectively.
Conclusion: We observed a significantly higher risk of BC in obese women among those eligible to participate in the MSP in the Province of Modena. Finally, obese women had more second events and poorer EFS compared to nono bese women.
Keywords: Body mass index; Breast neoplasms; Mammography; Mass screening; Outcome assessment.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Obesity in Postmenopausal Breast Cancer Patients: It Is Time to Improve Actions for a Healthier Lifestyle. The Results of a Comparison Between Two Italian Regions With Different "Presumed" Lifestyles.Front Oncol. 2021 Nov 18;11:769683. doi: 10.3389/fonc.2021.769683. eCollection 2021. Front Oncol. 2021. PMID: 34869002 Free PMC article.
-
The association between body mass index and immunohistochemical subtypes in breast cancer.Breast. 2017 Apr;32:227-236. doi: 10.1016/j.breast.2016.09.019. Epub 2016 Oct 15. Breast. 2017. PMID: 27756509
-
Changes in breast cancer incidence and stage distribution in Modena, Italy: the effect of a mammographic screening program.Cancer Causes Control. 2002 Oct;13(8):729-34. doi: 10.1023/a:1020208719902. Cancer Causes Control. 2002. PMID: 12420951
-
Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?Gynecol Oncol. 2014 Apr;133(1):56-62. doi: 10.1016/j.ygyno.2013.12.029. Gynecol Oncol. 2014. PMID: 24680592
-
High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients.Exp Oncol. 2015 Dec;37(4):281-4. Exp Oncol. 2015. PMID: 26710841
Cited by
-
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.NPJ Breast Cancer. 2021 Mar 22;7(1):31. doi: 10.1038/s41523-021-00232-w. NPJ Breast Cancer. 2021. PMID: 33753731 Free PMC article.
-
Rat Mammary carcinoma susceptibility 3 (Mcs3) pleiotropy, socioenvironmental interaction, and comparative genomics with orthologous human 15q25.1-25.2.G3 (Bethesda). 2023 Jan 12;13(1):jkac288. doi: 10.1093/g3journal/jkac288. G3 (Bethesda). 2023. PMID: 36315068 Free PMC article.
-
Effects of GSTT1 and GSTM1 polymorphisms in glutathione levels and breast cancer development in Brazilian patients.Mol Biol Rep. 2021 Jan;48(1):33-40. doi: 10.1007/s11033-020-06107-w. Epub 2021 Jan 16. Mol Biol Rep. 2021. PMID: 33452993
-
Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models.Breast Cancer Res. 2019 May 22;21(1):67. doi: 10.1186/s13058-019-1153-9. Breast Cancer Res. 2019. PMID: 31118047 Free PMC article.
-
Weighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk.J Mammary Gland Biol Neoplasia. 2020 Jun;25(2):115-131. doi: 10.1007/s10911-020-09452-5. Epub 2020 Jun 9. J Mammary Gland Biol Neoplasia. 2020. PMID: 32519090 Free PMC article. Review.
References
-
- Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296:193–201. - PubMed
-
- Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004;13:220–224. - PubMed
-
- Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer. 2002;44:127–138. - PubMed
-
- Sonnenschein E, Toniolo P, Terry MB, Bruning PF, Kato I, Koenig KL, et al. Body fat distribution and obesity in pre- and post-menopausal breast cancer. Int J Epidemiol. 1999;28:1026–1031. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials